Meetu C. Soni, DMD, BDS—a board-certified pediatric dentist in North Brunswick, New Jersey—is blogging for Decisions in Dentistry about COVID-19. In these trying times, providing dental care is stressful. Recommendations…

UPDATE: 6/9/2020 | 8:30am The World Health Organization (WHO) is clarifying original statements made by Maria Van Kerkhove, PhD, an infectious disease epidemiologist, during a WHO press conference on June 8 about the risk of COVID-19…

The response and aftermath to the global COVID-19 pandemic may encourage significant changes to the practice of dentistry, according to Lisa Simon, DMD, a Fellow in Oral Health and Medicine Integration at the Harvard School of Dental…

A new article in the American Journal of Infection Control asserts that asymptomatic children with COVID-19 could serve as significant sources of transmission for the virus, and that healthcare professionals who treat children, such as…

Most dental practices have gone the extra mile to procure N95 respirators for their employees, which, for many, has not been easy. However, some companies have been misleading in their claims that their N95 respirators will filter the…

One in four Americans will not get a vaccination to prevent COVID-19 when one becomes available, according to a Reuters/Ipnos poll. Experts suggest that 70% of the United States population will need to either recover from COVID-19, creating…

During a webinar hosted by the US Centers for Disease Control and Prevention’s (CDC) Clinician Outreach and Communication Activity on June 3, Alberto Garcia, MS, a mechanical engineer for the organization, highlighted some important…

Art shares promising statistics on reopening from an ADA survey, as well as from dental coaches on what they’re seeing with their clients.

Research, recently published in the Lancet, evaluates the efficacy of wearing masks and eye protection, as well as social distancing in reducing spread of the novel coronavirus. The meta-analysis found a significant decrease in infection…

A small trial of 32 patients is evaluating a new antibody drug developed specifically to fight the novel coronavirus. The trial will determine what, if any, side effects arise. Discovered by Vancouver-based AbCellera and developed by Eli…